311 related articles for article (PubMed ID: 31791413)
1. ALW peptide ameliorates lupus nephritis in MRL/lpr mice.
Wang H; Lu M; Zhai S; Wu K; Peng L; Yang J; Xia Y
Arthritis Res Ther; 2019 Dec; 21(1):261. PubMed ID: 31791413
[TBL] [Abstract][Full Text] [Related]
2. Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice.
Wang Y; Wang S; Liu W; Gu H; Luo M; Xiao T; Zhou M; Ran Y; Xiao S; Xia Y; Wang H
J Autoimmun; 2024 May; 145():103205. PubMed ID: 38493673
[TBL] [Abstract][Full Text] [Related]
3. A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens.
Xia Y; Eryilmaz E; Der E; Pawar RD; Guo X; Cowburn D; Putterman C
Clin Exp Immunol; 2016 Mar; 183(3):369-79. PubMed ID: 26482679
[TBL] [Abstract][Full Text] [Related]
4. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
Zhang Z; Liu D; Zhang X; Wang X
Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
[TBL] [Abstract][Full Text] [Related]
6. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
[TBL] [Abstract][Full Text] [Related]
8. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
[TBL] [Abstract][Full Text] [Related]
9. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J; Sun M; Tian S
Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
Zhao C; Gu Y; Chen L; Su X
Int Immunopharmacol; 2020 Dec; 89(Pt A):107027. PubMed ID: 33039957
[TBL] [Abstract][Full Text] [Related]
11. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
12. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
Front Immunol; 2018; 9():1948. PubMed ID: 30210500
[No Abstract] [Full Text] [Related]
13. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
14. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
Tan H; Zhao J; Wang S; Zhang L; Wang H; Huang B; Liang Y; Yu X; Yang N
Int Immunopharmacol; 2012 Dec; 14(4):401-9. PubMed ID: 22922317
[TBL] [Abstract][Full Text] [Related]
15. Anti-Double-Stranded DNA IgG Participates in Renal Fibrosis through Suppressing the Suppressor of Cytokine Signaling 1 Signals.
Wang P; Yang J; Tong F; Duan Z; Liu X; Xia L; Li K; Xia Y
Front Immunol; 2017; 8():610. PubMed ID: 28620377
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
[TBL] [Abstract][Full Text] [Related]
17. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
Hu Q; Yang C; Wang Q; Zeng H; Qin W
PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
[TBL] [Abstract][Full Text] [Related]
18. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
Sugahara K; Maeda Y; Shimano K; Murase M; Mochiduki S; Takemoto K; Kakimoto T; Utsumi H; Oshita K; Kataoka H
J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
[TBL] [Abstract][Full Text] [Related]
19. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Sun J; Guo S; Niu F; Liu D; Zhuang Y
Mol Med Rep; 2020 Dec; 22(6):5436-5443. PubMed ID: 33173997
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
Ding ZX; Yang SF; Wu QF; Lu Y; Chen YY; Nie XL; Jie HY; Qi JM; Wang FS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):656-60. PubMed ID: 21515463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
